As the application of PGAs could act as a confounding factor when assessing changes in glaucomatous AST, we compared the CCT, TM, SC, SS, and AST between two POAG subgroups (anti-glaucoma treatment with and without PGAs). The gene discussed is GOT1; the disease is open-angle glaucoma.